Market Closed -
Japan Exchange
01:52:52 2024-04-30 am EDT
|
5-day change
|
1st Jan Change
|
438
JPY
|
+4.04%
|
|
+6.05%
|
+13.47%
|
Fiscal Period: March |
2022
|
2023
|
---|
Capitalization
1 |
2,076
|
1,944
|
Enterprise Value (EV)
1 |
1,696
|
1,658
|
P/E ratio
|
11.4
x
|
56.6
x
|
Yield
|
-
|
-
|
Capitalization / Revenue
|
0.5
x
|
0.44
x
|
EV / Revenue
|
0.41
x
|
0.37
x
|
EV / EBITDA
|
5.52
x
|
6.48
x
|
EV / FCF
|
-
|
6,083,958
x
|
FCF Yield
|
-
|
0%
|
Price to Book
|
1.67
x
|
1.51
x
|
Nbr of stocks (in thousands)
|
5,378
|
5,400
|
Reference price
2 |
386.0
|
360.0
|
Announcement Date
|
6/27/22
|
6/28/23
|
Fiscal Period: March |
2022
|
2023
|
---|
Net sales
1 |
4,168
|
4,464
|
EBITDA
1 |
307
|
256
|
EBIT
1 |
156
|
99
|
Operating Margin
|
3.74%
|
2.22%
|
Earnings before Tax (EBT)
1 |
286
|
107
|
Net income
1 |
186
|
35
|
Net margin
|
4.46%
|
0.78%
|
EPS
2 |
33.74
|
6.360
|
Free Cash Flow
|
-
|
272.5
|
FCF margin
|
-
|
6.1%
|
FCF Conversion (EBITDA)
|
-
|
106.45%
|
FCF Conversion (Net income)
|
-
|
778.57%
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
6/27/22
|
6/28/23
|
Fiscal Period: March |
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Net sales
1 |
1,047
|
2,090
|
1,066
|
1,012
|
2,078
|
1,052
|
1,031
|
2,083
|
1,182
|
1,199
|
2,381
|
1,199
|
2,434
|
1,291
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
37
|
67
|
61
|
28
|
89
|
40
|
-5
|
35
|
-13
|
77
|
64
|
6
|
60
|
113
|
Operating Margin
|
3.53%
|
3.21%
|
5.72%
|
2.77%
|
4.28%
|
3.8%
|
-0.48%
|
1.68%
|
-1.1%
|
6.42%
|
2.69%
|
0.5%
|
2.47%
|
8.75%
|
Earnings before Tax (EBT)
1 |
71
|
162
|
85
|
39
|
124
|
41
|
4
|
45
|
-7
|
-
|
-
|
11
|
65
|
128
|
Net income
1 |
46
|
106
|
53
|
27
|
80
|
26
|
1
|
27
|
-18
|
26
|
8
|
2
|
33
|
82
|
Net margin
|
4.39%
|
5.07%
|
4.97%
|
2.67%
|
3.85%
|
2.47%
|
0.1%
|
1.3%
|
-1.52%
|
2.17%
|
0.34%
|
0.17%
|
1.36%
|
6.35%
|
EPS
2 |
-
|
19.90
|
9.720
|
-
|
-
|
4.970
|
-
|
5.020
|
-3.250
|
-
|
-
|
0.4500
|
6.370
|
15.45
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/12/21
|
11/12/21
|
2/14/22
|
5/13/22
|
5/13/22
|
8/12/22
|
11/14/22
|
11/14/22
|
2/13/23
|
5/15/23
|
5/15/23
|
8/14/23
|
11/14/23
|
2/14/24
|
Fiscal Period: March |
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
Net Cash position
1 |
380
|
286
|
Leverage (Debt/EBITDA)
|
-
|
-
|
Free Cash Flow
|
-
|
273
|
ROE (net income / shareholders' equity)
|
-
|
2.76%
|
ROA (Net income/ Total Assets)
|
-
|
2.06%
|
Assets
1 |
-
|
1,701
|
Book Value Per Share
2 |
232.0
|
239.0
|
Cash Flow per Share
2 |
210.0
|
205.0
|
Capex
1 |
37
|
32
|
Capex / Sales
|
0.89%
|
0.72%
|
Announcement Date
|
6/27/22
|
6/28/23
|
|
1st Jan change
|
Capi.
|
---|
| +13.47% | 14.25M | | -14.58% | 85.02B | | +15.05% | 82.37B | | +10.49% | 29.29B | | -10.17% | 17.21B | | -0.82% | 16.7B | | -31.40% | 11.8B | | +2.21% | 12.15B | | +31.86% | 12.12B | | -1.59% | 12.13B |
Other Healthcare Facilities & Services
|